Lauri Sippola, Co-founder & CEO at Gosta Labs | Slush 2025
summary
Gosta Labs builds an AI operating system for oncology teams that ingests fragmented records, auto-structures notes and supports tumor board workflows; models are trained on the Lumi supercomputer in northern Finland to keep data private. Clinical data presented at ESMO show oncology teams complete complex notes in a median time under two minutes versus 10–20 minutes before. Deployment spans Europe and APAC with North America coming, product aims to handle rising complexity (35M new cases by 2050, 700 late-stage modalities) and closed a €7.5M seed round.
AI-written summary · about
related talks
06mGenesis Startup Competition Pitch - Drylab AI
10mGenesis Final Round - Drylab AI
50mCancer Genomics - a biologist and a developer
10mGenesis Final Round - Preveta
21mCreating Markets, Creating Trustworthiness: Standards for AI
47mGood News from Europe
24mTechnology’s Next Frontiers
28mThe Future of Healthcare – AI’s Promise and the Challenges Ahead